Posters

Choose an Event

ASM Microbe 2016

Activity of Novel Oxazolidinone Tedizolid against Clinical Gram-Positive Pathogens Collected from Canadian Hospitals: CANWARD 2013-15

A.R. Golden, H.J. Adam, M. Baxter, K.A. Nichol, B. Weshnoweski, R. Vashisht, S. Biju, J.A. Karlowsky, D.J. Hoban,G.G. Zhanel, and the Canadian Antimicrobial Resistance Alliance (CARA)

PDF 299Kb Download

 

Antimicrobial Susceptibility of 39,816 Pathogens Isolated from Patients in Canadian Hospitals: CANWARD Study 2007-2015

G.G. Zhanel, H.J. Adam, M. Baxter, B. Weshnoweski, R. Vashisht, S. Biju, N. Laing, K. Nichol, A. Denisuik, A. Golden, P. Lagacé-Wiens, J. Fuller, J.A. Karlowsky, A. Walkty, M. Gilmour, D. Bay, F. Schweizer, M.R. Mulvey, G.R. Golding, CARA, and D.J. Hoban

PDF 660Kb Download

 

Activity of Eravacycline and Comparators against 6,380 Pathogens Isolated from Canadian Hospitals: CANWARD 2014 and 2015

G.G. Zhanel, H. Adam, M. Baxter, B. Weshnoweski, R. Vashisht, S. Biju, A. Golden, A. Denisuik, A. Walkty, P. Lagacé-Wiens, J.A. Karlowsky and D.J. Hoban

PDF 412Kb Download

 

In Vitro Activity of Ceftazidime-Avibactam (CAZ-AVI) and Comparators against Gram-Negative Pathogens Isolated from Patients in Canadian Hospitals in 2009-2015: CANWARD Surveillance Study

P. Lagacé-Wiens, H. Adam, A. Denisuik, M. Baxter, J. Karlowsky, A. Walkty, D. Hoban, G. G. Zhanel and the Canadian Antimicrobial Resistance Alliance (CARA)

PDF 239Kb Download

 

ICAAC 2015

Rates of Extended-Spectrum β-Lactamase-Producing Escherichia coli Quadruple in Canadian Hospitals Over an 8-year Period: CANWARD 2007-2014

A.J. Denisuik, H.J. Adam, P. Lagacé-Wiens, P.J. Simner, M.R. Mulvey, M. Baxter, M. Gilmour, J.A. Karlowsky, D.J. Hoban, G.G. Zhanel, and the Canadian Antimicrobial Resistance Alliance (CARA)

PDF 312Kb Download

 

Antimicrobial Susceptibility of Bacterial Pathogens Isolated from Canadian Intensive Care Units from 2007 to 2014: Results of the CANWARD Study

L.A. Garbutt, A.J. Denisuik, H.J. Adam, M. Baxter, P.R.S. Lagacé-Wiens, J.A. Karlowsky, D.J. Hoban, G.G. Zhanel, and the Canadian Antimicrobial Resistance Alliance (CARA)

PDF 345Kb Download

 

Characterization of Emerging Non-PCV-13 Streptococcus pneumoniae (SPN) Serotypes 22F and 33F Causing Invasive Infections in Canada, 2011-2014

A.R. Golden, H.J. Adam, A. Tsibulski, C. Lawrence, M. Gilmour, M. Baxter, I. Martin, K.A. Nichol, W. Demczuk, J.A. Karlowsky, D.J. Hoban, G.G. Zhanel, and the Canadian Antimicrobial Resistance Alliance (CARA)

PDF 657Kb Download

 

Antimicrobial Resistance in Streptococcus pneumoniae Isolated in Canada: Comparison of Blood and Respiratory Isolates, CANWARD 2007-2014

A.R. Golden, H.J. Adam, M. Baxter, K.A. Nichol, I. Martin, W. Demczuk, M. Gilmour, J.A. Karlowsky, D.J. Hoban, G.G. Zhanel, and the Canadian Antimicrobial Resistance Alliance (CARA)

PDF 696Kb Download

 

Characterization of the 10 Most Common Serotypes Causing Invasive Pneumococcal Disease in Canada, 2011-2014

A.R. Golden, H.J. Adam, J. Klassen, M. Gilmour, M. Baxter, I. Martin, K.A. Nichol, W. Demczuk, J. Embree, J.A. Karlowsky, D.J. Hoban, G.G. Zhanel, and the Canadian Antimicrobial Resistance Alliance (CARA)

PDF 270Kb Download

 

In Vitro Activity of Tedizolid against Gram-Positive Pathogens Isolate in Canadian Hospitals: CANWARD 2013-15

A.R. Golden, H.J. Adam, M. Baxter, K.A. Nichol, B. Weshnoweski, R. Vashisht, S. Biju, J.A. Karlowsky, D.J. Hoban, G.G. Zhanel, and the Canadian Antimicrobial Resistance Alliance (CARA)

PDF 294Kb Download

 

Activity of Eravacycline and Comparators against 3,174 Pathogens Isolated from Canadian Hospitals: CANWARD 2014

G.G. Zhanel, H. Adam, M. Baxter, B. Weshnoweski, R. Vashisht, S. Biju, A. Golden, A. Denisuik, A. Walkty, P. Lagacé-Wiens, J.A. Karlowsky, and D.J. Hoban

PDF 538Kb Download

 

Pharmacodynamic Activity of Fosfomycin versus Multidrug-Resistant (MDR) Genotypically CharacterizedExtended Spectrum ß-lactamase (ESBL) - and/or Carbapenemase-Producing Escherichia coli using an In vitro Model

G.G. Zhanel, K. Parkinson, S. Higgins, A. Denisuik, H. Adam, J. Pitout, P. Lagacé-Wiens, D.J. Hoban, J.A. Karlowsky, and the Canadian Antimicrobial Resistance Alliance (CARA)

PDF 303Kb Download

 

Antimicrobial Susceptibility of 36,607 Pathogens Isolated from Patients in Canadian Hospitals: CANWARD Study 2007-2014

G.G. Zhanel, H.J. Adam, M. Baxter, B. Weshnoweski, R. Vashisht, M. Ismath, R. Hink, K. Nichol, A. Denisuik, A.Golden, P. Lagacé-Wiens, J.A. Karlowsky, M. Gilmour, D. Bay, M.R. Mulvey, and the Canadian Antimicrobial Resistance Alliance (CARA)

PDF 619Kb Download

 

Current Epidemiology and Antimicrobial Resistance of Streptococcus pneumoniae (SPN) in Canada: SAVE 2014

H.J. Adam, A. Golden, M. Gilmour, M. Baxter, I. Martin, K.A. Nichol, W. Demczuk, J.A. Karlowsky, D.J. Hoban, G.G. Zhanel, and the Canadian Antimicrobial Resistance Alliance (CARA)

PDF 424Kb Download

 

Pathogens and Their Antimicrobial Resistance Patterns in Emergency Departments (EDs) across Canada: CANWARD 2007-2014

K.J. Thompson, H.J. Adam, M. Baxter, P.R.S. Lagacé-Wiens, J.A. Karlowsky, A. Walkty, D.J. Hoban, the Canadian Antimicrobial Resistance Alliance (CARA), and G.G. Zhanel

PDF 292Kb Download

 

Characterization of Community- and Healthcare-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) in Canadian Hospitals from 2007-2014

K.A. Nichol, H.J. Adam, G.R. Golding, M. McCracken, M.R. Baxter, M.W. Gilmour, J.A. Karlowsky, D.J. Hoban, G.G. Zhanel, and the Canadian Antimicrobial Resistance Alliance (CARA)

PDF 341Kb Download

 

Activity of Telavancin against Gram-Positive Cocci from Canadian Hospitals using Revised CLSI Guidelines: CANWARD 2013 and 2014

K.A. Nichol, H.J. Adam, N. Laing, B. Weshnoweski, R. Vashisht, M.R. Baxter, J.A. Karlowsky, D.J. Hoban, G.G. Zhanel, and the Canadian Antimicrobial Resistance Alliance (CARA)

PDF 248Kb Download

 

In Vitro Activity of Ceftazidime-Avibactam (CAZ-AVI) and Comparators Against Gram-negative Pathogens Isolated from Patients in Canadian Hospitals in 2009-2014: CANWARD Surveillance Study

P. Lagacé-Wiens, H. Adam, A. Denisuik, M. Baxter, J. Karlowsky, A. Walkty, D. Hoban, G. G. Zhanel, and the Canadian Antimicrobial Resistance Alliance (CARA)

PDF 240Kb Download

 

Use of 0.002% Polysorbate-80 (PS-80) for Determination of Colistin MICs Produces Results that are Compatible with Colistin Pharmacokinetics/Pharmacodynamics

P. Lagacé-Wiens, J. Karlowsky, R. Ariano, S. Zelenitsky, A. Walkty, D. J. Hoban, the Canadian Antimicrobial Resistance Alliance (CARA) and G. G. Zhanel

PDF 303Kb Download

 

Antimicrobial Susceptibility of Clinical Isolates of Neisseria gonorrhoeae to Unconventional Antimicrobials with Therapeutic Potential: Results of the Canadian Antimicrobial Resistance Initiative for Neisseria gonorrhoeae (CARING)

P. Lagacé-Wiens, H. Adam, M. Baxter, M. Gilmour, I. Martin, M. R. Mulvey, J. Karlowsky, D. J. Hoban, the Canadian Antimicrobial Resistance Alliance (CARA), and G. G. Zhanel

PDF 226Kb Download

 

CACMID 2014

CANWARD 2013: Antimicrobial Resistance in Pathogens Isolated from Canadian Hospital Clinics, Emergency Rooms, Medical/Surgical Wards and Intensive Care Units

M. Baxter, H.J. Adam, M. McCracken, A. Denisuik, G. Golding, J.A. Karlowsky, D.J. Hoban, and G.G. Zhanel

PDF 217Kb Download

 

ICAAC 2014

Epidemiology and Antimicrobial Susceptibilities of Pathogens Isolated from Blood Cultures from Canadian Hospitals: CANWARD 2007-2013 Study

P.J. Simner, H. Adam, M. Baxter, A. Denisuik, J.A. Karlowsky, K. Nichol, P. Lagacé-Wiens, M. Gilmour, Canadian Antimicrobial Resistance Alliance, D.J. Hoban and G.G. Zhanel

PDF 494Kb Download

 

Trends in antimicrobial resistance in Canada over seven years: Not All Bad News?

P. Lagacé-Wiens, H. Adam, M. Baxter, J. Karlowsky, A. Walkty, P. Simner, M. Gilmour, M. Mulvey, D. Hoban, G.G. Zhanel, and the Canadian Antimicrobial Resistance Alliance

PDF 176Kb Download

 

In vitro activity of Fidaxomicin and its metabolite OP-1118 against clinical isolates of toxin-positive C. difficile cultured from diarrheal stool specimens in Canada: CAN-DIFF 2013

J.A. Karlowsky, S. Vashisht, G. Golding, H. Adam, T. Kosowan, M. Baxter, N. Laing, D.J. Hoban, G.G. Zhanel, and the Canadian Antimicrobial Resistance Alliance (CARA)

PDF 229Kb Download

 

In vitro activity of CAZ-AVI and comparators against Gram-negative pathogens isolated from patients in Canadian hospitals in 2009-2013: CANWARD surveillance study

P. Lagacé-Wiens, H. Adam, A. Denisuik, M. Baxter, J. Karlowsky, P.J. Simner, R. Vashisht, A. Walkty, D. Hoban, G.G. Zhanel and the Canadian Antimicrobial Resistance Alliance (CARA)

PDF 181Kb Download

 

In vitro activity of Oritavancin against Gram-Positive pathogens isolated in Canadian hospitals from 2011 to 2013

J.A. Karlowsky, H.J. Adam, M.R. Baxter, B. Weshnoweski, R. Vashisht, D.J. Hoban, and G.G. Zhanel

PDF 223Kb Download

 

Activity of Telavancin against Gram-Positive Cocci from CANWARD 2007-2013 using previously established and revised CLSI guidelines

K.A. Nichol, H.J. Adam, N. Laing, B. Weshnoweski, R. Vashisht, M.R. Baxter, J.A. Karlowsky, D.J. Hoban and G.G. Zhanel

PDF 280Kb Download

 

Changing epidemiology of community-associated methicillin-resistant S. aureus (CA-MRSA) in Canadian hospitals from 2007-2013

K.A. Nichol, H.J. Adam, G.R. Golding, M. McCracken, M.R. Baxter, M.W. Gilmour, J.A. Karlowsky, D.J. Hoban, and G.G. Zhanel

PDF 365Kb Download

 

Denisuik, A – The continued rise of extended-spectrum ß-Lactamase-, AmpC ß-Lactamase-, and carbapenemase-producing E. coli (EC) and K. pneumoniae (KPN) in Canadian hospitals: CANWARD 2007-2013

A.J. Denisuik, H.J. Adam, P. Lagacé-Wiens, P.J. Simner, M.R. Mulvey, M. Baxter, W. MacDougall, M. Gilmour, J.A. Karlowsky, D.J. Hoban and G.G. Zhanel

PDF 270Kb Download

 

Vancomycin-resistant Enterococci (VRE) in Canadian hospitals: CANWARD 2007-2013

P.J. Simner, H. Adam, M. Baxter, M. Mccracken, M.R. Mulvey, J.A. Karlowsky, K. Nichol, P. Lagacé-Wiens, M. Gilmour, Canadian Antimicrobial Resistance Alliance (CARA), D.J. Hoban and G.G. Zhanel

PDF 317Kb Download

 

Pharmacodynamic activity of ertapenem vs. multi-drug resistant (MDR) genotypically characterized extended spectrum ß-lactamase (ESBL) producing E. coli at standard and high inocula using an in vitro model

G.G. Zhanel, S. Vashisht, C. Yachison, A. Denisuik, H. Adam, N. Laing, J. Pitout, P. Lagacé-Wiens, D.J. Hoban and J.A. Karlowsky

PDF 306Kb Download

 

In vitro activity of fosfomycin against bacterial pathogens isolated from outpatient urine specimens in Canada from 2007 to 2013

J.A. Karlowsky, H.J. Adam, M.R. Baxter, J. Dupuis, N. Laing, B. Weshnoweski, R. Vashisht, and G.G. Zhanel

PDF 372Kb Download

 

Characterization of multi-drug resistant (MDR) and extensively-drug resistant (XDR) S. pneumoniae in Canadian hospitals, 2007-2013

A.R. Golden, B. Fultz, M. Rosenthal, K.A. Nichol, H.J. Adam, M.W. Gilmour, M. Baxter, D.J. Hoban, J.A. Karlowsky, G.G. Zhanel, and Canadian Antimicrobial Resistance Alliance (CARA)

PDF 443Kb Download

 

Characterization of potentially emerging S. pneumoniae (SPN) non-vaccine serotypes (NVS) 15A, 22F, 33F and 35B in Canada, 2011-13

A.R. Golden, H.J. Adam, T. Denisuik, M.W. Gilmour, M. Baxter, I. Martin, K.A. Nichol, W. Demczuk, D.J. Hoban, G.G. Zhanel, and Canadian Antimicrobial Resistance Alliance (CARA)

PDF 399Kb Download

 

Ongoing evolution in the epidemiology and antimicrobial resistance of S. pneumoniae in Canada in the PCV-13 Era: SAVE 2013

H.J. Adam, A. Golden, M. Gilmour, M. Baxter, I. Martin, K.A. Nichol, W. Demczuk, R. Vashisht, J.A. Karlowsky, D.J. Hoban, and G.G. Zhanel

PDF 220Kb Download

 

CACMID 2013

CANWARD 2012: Antimicrobial Resistance in Pathogens Isolated from Canadian Hospital Clinics, Emergency Rooms, Medical/Surgical Wards and Intensive Care Units

M. Baxter, H.J. Adam, M. McCracken, A. Denisuik, G. Golding, J.A. Karlowsky, D.J. Hoban, and G.G. Zhanel

PDF 773Kb Download

 

Antifungal Susceptibility of Respiratory Aspergillus Isolates from Canadian Hospitals: Results of the CANWARD 2012 Study

J. Fuller, S. Jiwa, S. Shokoples, L. Turnbull, R. Rennie, M.Baxter, H. Adam, D.J. Hoban, and G.G. Zhanel

PDF 379Kb Download

 

ICAAC 2013

Golden, A – In Vitro Activity of Tedizolid against Canadian Clinical Gram-Positive Pathogens, Including hVISA and the CDC NARSA Strains

A. Golden, M. Baxter, K.A. Nichol, B. Weshnoweski, R. Vashisht, H.J. Adam, D.J. Hoban and G.G. Zhanel

PDF 297Kb Download

 

Nichol, K – Changing Epidemiology of Community-Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA) in Canadian Hospitals from 2007-2012

K.A. Nichol, H.J. Adam, G.R. Golding, M. Mccracken, M. Baxter, C. Yachison, P. Lagacé-Wiens, D.J. Hoban and G.G. Zhanel

PDF 348Kb Download

 

Adam, H – The Impact of PCV-13: Changes in the Epidemiology and Antimicrobial Resistance of Streptococcus pneumoniae in Canada, 2007-9 versus 2011-12

H.J. Adam, A. Golden, M. Gilmour, M. Baxter, I. Martin, K.A. Nichol, W. Demczuk, D.J. Hoban, and G.G. Zhanel

PDF 199Kb Download

 

Denisuik, A - High National Prevalence of Extended Spectrum β-Lactamase Producing Escherichia coli Isolated from Canadian Hospitals Maintained in 2012: CANWARD 2007-2012

A.J. Denisuik, H.J. Adam, P. Lagacé-Wiens, P.J. Simner, M.R. Mulvey, M. Baxter, D.J. Hoban and G.G. Zhanel

PDF 300Kb Download

 

Zhanel, G - In vitro Activity of Ceftolozane/Tazobactam against 5,715 Gram-Negative and Gram-Positive Pathogens Isolated from Patients in Canadian Hospitals in 2011 and 2012: CANWARD Surveillance Study

G. G. Zhanel, H. J. Adam, M. Baxter, A. Walkty, P. R. S. Lagacé-Wiens, A. Denisuik, B. Weshnoweski, R. Vashisht, D. J. Hoban and J. A. Karlowsky

PDF 354Kb Download

 

Zhanel, G – In Vitro Activity of Fosfomycin Against Urinary Tract Isolates of Escherichia coli Isolated From Patients Across Canada from 2010 to 2013

J.A. Karlowsky, P. R.S. Lagacé-Wiens, B.Weshnoweski, R.Vashisht, A.J. Denisuik, H. J. Adam, M.R. Baxter, D.J. Hoban, And G.G. Zhanel

PDF 278Kb Download

 

Nichol, K – Activity of Telavancin against 8,686 Gram-Positive Cocci Associated with Infections in Canadian Hospitals from 2007-2012

K.A. Nichol, H.J. Adam, N. Laing, B. Weshnoweski, R. Vashisht, M.R. Baxter, D.J. Hoban And G.G. Zhanel

PDF 178Kb Download

 

ICAAC 2012

Dramatic Increase in the Prevalence of ESBL-Producing Escherichia coli (EC) in Canadian Hospitals Over a 5-Year Period

A.J. Denisuik, P.J. Simner, F. Tailor, H.J. Adam, P. Lagacé-Wiens, M.R. Mulvey, M. Baxter, D.J. hoban and G.G. Zhanel

PDF 285Kb Download

 

In Vitro Activity of Plazomicin Against Gram-Negative and Gram-Positive Pathogens Isolated from Patients in Canadian Hospitals in 2011: CANWARD Surveillance Study

G.G. Zhanel, H.J. Adam, M. Baxter, A. Denisuik, P. P. R. Lagacé-Wiens, F. Schweizer, D.J. Hoban, J.A. Karlowsky

PDF 285Kb Download

 

Antimicrobial Susceptibility of 27,123 Pathogens Isolated from Patients in Canadian Hospitals: CANWARD Study 2007 - 2011

G.G. Zhanel, H.J. Adam, M. Baxter, K. Nichol, A. Denisuik, P. Lagacé-Wiens, A. Walkty, J.A. Karlowsky, F. Schweizer, Canadian Antimicrobial Resistance Alliance-CARA and D.J. Hoban

PDF 285Kb Download

 

Multi-drug Resistance in the Most Prevalent Invasive Streptococcus pneumoniae (SPN) Serotypes (STs) Post PCV-13 Introduction in Canada

H.J. Adam, M. Gilmour, M. Baxter, I. Martin, L. Scharikow, K.A. Nichol, W. Demczuk, J. Embree, D.J. Hoban, and G.G. Zhanel

PDF 285Kb Download

 

Continuing Evolution of USA300 (CMRSA10) Community-Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA) in Canadian Hospitals from 2007-2011

K.A. Nichol, H.J. Adam, M.R. Mulvey, M. McCracken, M. Baxter, A. Onio, D.J. Hoban and G.G. Zhanel

PDF 285Kb Download